Trends in Use of Pulmonary Rehabilitation Among Older Adults with Chronic Obstructive Pulmonary Disease Anita C. Mercado, Shawn P. Nishi, Wei Zhang, Yong-Fang.

Slides:



Advertisements
Similar presentations
Bill Stockdale, MBA, Celeste Beck, MPH, Lisa Hulbert, PharmD, Wu Xu, PhD Utah Department of Health Comparison with other methods of analysis: 1) Assessing.
Advertisements

1 Costs and Rehabilitation of Stroke Patients: A Retrospective Study of Medicare Beneficiaries Richard D. Zorowitz, MD 1 ; Er Chen, MPP 2 ; Kuo B. Tong,
Preventable Hospitalizations: Assessing Access and the Performance of Local Safety Net Presented by Yu Fang (Frances) Lee Feb. 9 th, 2007.
1 Proprietary and Confidential 1 Identification of Potentially Avoidable Emergency Department Visits Using Claims Data APHA Session : Advances in.
BACKGROUND Incidence of Myelodysplastic Syndromes in the United States Medicare Population  The myelodysplastic syndromes (MDS) are a heterogeneous group.
Delay from Testing HIV Positive until First HIV Care for Drug Users: Adverse Consequences and Possible Solutions Barbara J Turner MD, MSEd* John Fleishman.
RACIAL DISPARITIES IN PRESCRIPTION DRUG UTILIZATION AN ANALYSIS OF BETA-BLOCKER AND STATIN USE FOLLOWING HOSPITALIZATION FOR ACUTE MYOCARDIAL INFARCTION.
Chapter 5: Acute Kidney Injury 2014 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Hospitalizations for Severe Sepsis Among Elderly Medicare Beneficiaries William Buczko, Ph.D. Research Analyst Centers for Medicare & Medicaid Services.
The Big Puzzle Evolving the Continuum of Care. Agenda Goal Pre Acute Care Intra Hospital Care Post Hospital Care Grading the Value of Post Acute Providers.
Outcomes of the Shift in Care from Inpatient to Outpatient Procedures in Hysterectomy Stephanie Makepeace.
Frequency of Asthma Education in Primary Care for the Years Marquise Lee, MSCR 1, Kevin Cross, PharmD, MSCR 1, Wan Yu Yang, MSCR 1, Michael Jiroutek,
Morbidity & Mortality: 2012 Chart Book on Cardiovascular, Lung, and Blood Diseases National Heart, Lung, and Blood Institute February, 2012.
CARDIOVASCULAR DISEASE National Healthcare Quality and Disparities Report Chartbook on Effective Treatment.
Surveillance for Asthma: Measuring a Moving Target David M. Mannino Air Pollution and Respiratory Health Branch Centers for Disease Control and Prevention.
Snapshot of IMS LifeLink Claims Database 10% Random Sample
Quality Measurement and Gender Differences in Managed Care Populations with Chronic Diseases Ann F. Chou Carol Weisman Arlene Bierman Sarah Hudson Scholle.
AcademyHealth 2007 Gender Differences in Healthcare Utilization at the End-of Life Andrea Kronman, MD MSc Boston University BIRCWH Faculty Scholar Women’s.
Medicare Home Health and The Role of Physicians Jennifer L. Wolff, Ann Meadow, Carlos O. Weiss, Cynthia M. Boyd, Bruce Leff June 2008.
DataBrief: Did you know… DataBrief Series ● February 2013 ● No. 38 Medicare Spending for Beneficiaries with Severe Mental Illness and Substance Use Disorder.
THE URBAN INSTITUTE Examining Long-Term Care Episodes and Care History for Medicare Beneficiaries: A Longitudinal Analysis of Elderly Individuals with.
Racial Disparities in Primary Care and Utilization of Health Services at the End-of-Life Andrea Kronman, MD Boston University School of Medicine.
Addressing Racial/Ethnic Differences in ADHD Diagnosis and Treatment Among Medicaid-insured Youth in California Dinci Pennap, MPH, 1 Mehmet Burcu, MS,
Hospital racial segregation and racial disparity in mortality after injury Melanie Arthur University of Alaska Fairbanks.
Urban/Rural Differences in Survival Among Medicare Beneficiaries with Breast Cancer Melony E.S. Sorbero, Ph.D. RAND Corporation Funded by Health Resources.
Primary Care Continuity and Health Care Expenditures in a Depressed Sample of Florida Medicaid Recipients Andrea M. Lee, M.S. Robert G. Frank, Ph.D. Zoe.
Chapter 5: Acute Kidney Injury 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Printed by A Follow-Up Study of Patterns of Service Use and Cost of Care for Discharged State Hospital Clients in Community-Based.
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Discharges to Home Health and Postacute Care Berry JG, Hall M, Dumas H, et al. Pediatric.
A Perspective on Family Medicine and End-of-Life and Palliative Care Peter Selwyn, M.D., M.P.H. Professor and Chairman Department of Family & Social Medicine.
Click to begin. Click here for Bonus round OIG Issues Medicare & Medicaid General 100 Point 200 Points 300 Points 400 Points 500 Points 100 Point 200.
Acute Renal Failure in Aneurysmal Subarachnoid Hemorrhage: Nationwide Analysis of Hospitalizations in the United States Kavelin Rumalla 1, Adithi Y. Reddy.
2016 Annual Data Report, Vol 2, ESRD, Ch 5
R. Papani, A. G. Duarte, Y-L. Lin, G. Sharma
UNDERSTANDING THE MENTAL HEALTH SERVICE NEEDS OF DEPRESSED OLDER ADULTS: A STUDY OF AGE DIFFERENCES IN RECEIPT OF EVIDENCE BASED TEREATMENT FOR MAJOR.
Pulmonary Rehabilitation
Characteristics of patients Without renal recovery
Cheryl Schraeder, RN, PhD, FAAN Health Systems Research Center
American Public Health Association
PCI related in-hospital mortality based on race and gender in the USA
Date:2017/10/03 Presenter: Wen-Ching Lan
Resolving outcome disparities in depression for minority primary care patients with collaborative care management Kurt B. Angstman, MS MD Associate Professor.
Description of Project
Medical Care Cost of Medicare/Medicaid Beneficiaries with Vision Loss
Chapter 2: Identification and Care of Patients With CKD
2016 Annual Data Report, Vol 1, CKD, Ch 2
Chapter 12: End-of-life Care for Patients with ESRD:
Evaluating Sepsis Guidelines and Patient Outcomes
Clinical differences between freestanding and hospital-based emergency departments May 18, 2017 Ryan C. Burke, MPH.
Courtney selby, Pharm.d. arcare pgy1 Community pharmacy resident
Volume 1: Chronic Kidney Disease Chapter 5: Acute Kidney Injury
Volume 1: Chronic Kidney Disease Chapter 3: Morbidity and Mortality
Menachem M Meller,MD, PhD
VSAC and Quality Measures
Surveillance of People with IDD Using Medicaid and Commercial Claims
Antimicrobial Therapy (Vancomycin and/or Metronidazole)
2016 Annual Data Report, Vol 2, ESRD, Ch 14
19 Medical Coding.
2018 Annual Data Report Volume 1: Chronic Kidney Disease
Chapter 3: Morbidity and Mortality
Chapter 2: Identification and Care of Patients with CKD
Chapter 12: End-of-life Care for Patients with ESRD:
Comorbidity status in patients with CKD stage 4 or 5 not on dialysis, peritoneal dialysis, haemodialysis and transplanted patients (bars), as well as in.
Comprehensive Medical Assisting, 3rd Ed Unit Three: Managing the Finances in the Practice Chapter 14 - Diagnostic Coding.
John Malaty, MD Peter J. Carek, MD, MS Maribeth Porter, MD, MSCR
Part 1: Data Sources Frank Porell
15 TRICARE Medical Billing.
Risk factors for postoperative infection after lower gastrointestinal surgery in patients with inflammatory bowel disease: Findings from a large epidemiological.
Khai Hoan Tram, Jane O’Halloran, Rachel Presti, Jeffrey Atkinson
Chapter 2: Identification and Care of Patients with CKD
Presentation transcript:

Trends in Use of Pulmonary Rehabilitation Among Older Adults with Chronic Obstructive Pulmonary Disease Anita C. Mercado, Shawn P. Nishi, Wei Zhang, Yong-Fang Kuo, Gulshan Sharma Department Name Goes Here

Disclosures No disclosures

Pulmonary rehabilitation Evidence-based, multidisciplinary and comprehensive intervention for patients with chronic respiratory disease Symptomatic with decreased daily life activities Individualized treatment designed Reduce symptoms Optimize functional status Increased participation Possibly reduced healthcare costs By stabilizing or reversing systemic manifestations Evid … for pts with chronic resp dz Indiv tx designed to ATS/ERS statement on pulmonary rehabilitation. Am J of Respiratory Crit Care Med 2006: 173 (12): 1390 – 1413.

Pulmonary rehabilitation Standard of care for chronic lung disease ATS/ERS COPD- largest number of PR referrals Majority of the literature focuses on COPD (ATS/ERS 2006, Toosters 2005) Systemic effects of the illness well described Medicare approved pulmonary rehabilitation ***for ### sessions/yr over lifetime. Standard of care- based on a body of literature-PR

Background Medicare approved pulmonary rehabilitation ***for ### sessions/yr over lifetime. Standard of care- based on a body of literature-PR

Objective PR use in the general population remains low. We examined the rate of pulmonary rehabilitation and factors associated with receipt of pulmonary rehabilitation in patients with COPD using a 5% national sample of Medicare beneficiaries. Standard of care- based on a body of literature-PR

Methods: Design Retrospective study Pulmonary rehab use in COPD subjects Period: 2003-2009 Center for Medicare and Medicaid Services select a random sample 5% sample base on 8th and 9th digits Health insurance claim number (05, 20, 45, 70, 95) standard available for research purposes has been shown to be representative of the whole cohort [1]. Medicare data file descriptions. [cited January 24, 2013]; Available from: www.resdac.umb.edu/Medicare/file_descritions.asp.

Methods: Study Cohort 491.x [chronic bronchitis] 492.x [emphysema] or Diagnosis of COPD Two outpatient or consultation visits E &M codes: 99201-99205, 99211-99215 or 99241-99245 At least 30 days apart in one year One acute care hospitalization with 1° discharge diagnosis of COPD Based on the following ICD-9 codes 491.x [chronic bronchitis] 492.x [emphysema] or 496 [chronic airway obstruction] A patient met the diagnosis of COPD who had any of the following:; Evaluation and Management codes; International Classification of Diseases, 9th revision (ICD-9)

Methods: Study Cohort Separate denominator file of beneficiaries (2003, 2006, 2009): Diagnosis of COPD Age ≥66 years Complete enrollment (Part A and? B) ± in year Not enrolled in an HMO Not a resident of a nursing facility ± in year Each file was composed of participants in the year of interest who: 1) had a diagnosis of COPD; 2) was age ≥66 years; 3) had complete enrollment (Part A, Part B) in the year prior to and the year of interest; 4) were not enrolled in a health maintenance organization [HMO]); and 5) were not a resident of a nursing facility in the year of interest or one year prior.

Variables Age (66–74, 75–84, ≥85 years) Gender: M/F Race/ethnicity -White, Black and Others Medicaid eligibility (state buy-in) proxy for low socioeconomic status comorbidity score (0, 1, 2, ≥3) 27 Elixhauser comorbidity score (excluding COPD) from inpatient and outpatient billing data [2, 3]. Geographic regions- 9 CMS regions Elixhauser, A., et al., Comorbidity measures for use with administrative data. Med Care, 1998. 36(1): p. 8-27. Comorbidity Software, Version 3.7. 2013 [cited Jan 2013]; Available from: http://www.hcup-us.ahrq.gov/toolssoftware/comorbidity/comorbidity.jsp.

Outcome Measures PR performed in each year of interest for subjects with COPD PR identified- healthcare common procedure coding system (HCPCS) Codes: G0237, G0238, G0239 E&M codes (97001, 97003, 97110, 97116, 97124, 97139, 97150, 97530, 97535, 97537) with Primary ICD-9 codes (491.x, 492.x, or 496.x). Our outcome of interest was pulmonary rehabilitation performed in each calendar year of interest for subjects with COPD. Pulmonary rehabilitation was identified through the healthcare common procedure coding system (HCPCS) codes (G0237, G0238, G0239) or the evaluation and management (E&M) codes (97001, 97003, 97110, 97116, 97124, 97139, 97150, 97530, 97535, 97537) with primary ICD-9 codes (491.x, 492.x, or 496.x).

Characteristics of PR utilization among COPD patients (2003-2009)   COPD patients of 2003 COPD patients of 2006 COPD patients of 2009 Total PR No-PR Overall 33526 869 (2.59) 32657 (97.4) 32337 1082 (3.35) 31255 (96.7) 30255 1100 (3.64) 29155 (96.4) Age 66-74 16134 503 (3.12) 15631 (96.9) 15185 597 (3.93) 14588 (96.1) 12825 521 (4.06) 12304 (95.9) 75-84 14464 336 (2.32) 14128 (97.7) 14040 421 (3.00) 13619 (97.0) 13313 493 (3.70) 12820 (96.3) >=85 2928 30 (1.02) 2898 (98.9) 3112 64 (2.06) 3048 (97.9) 4117 86 (2.09) 4031 Gender Male 16652 394 (2.37) 16258 (97.6) 16043 560 (3.49) 15483 (96.5) 14759 542 (3.67) 14217 Female 16874 475 (2.81) 16399 (97.2) 16294 522 (3.20) 15772 (96.8) 15496 558 (3.60) 14938 Race White 30490 831 (2.73) 29659 (97.3) 29465 1027 28438 27567 1045 (3.79) 26522 (96.2) Black 1842 26 (1.41) 1816 (98.6) 1660 32 (1.93) 1628 (98.1) 1618 35 (2.16) 1583 (97.8) Others 1194 12 (1.01) 1182 1212 23 (1.90) 1189 (98.1) 1070 20 (1.87) 1050 Low socioeconomic No 27916 778 (2.79) 27138 26955 977 (3.62) 25978 25224 998 (3.96) 24226 (96.0) Yes 5610 91 (1.62) 5519 (98.4) 5382 105 (1.95) 5277 5031 102 (2.03) 4929

Characteristics of PR utilization among COPD patients (2003-2009)   COPD patients of 2003 COPD patients of 2006 COPD patients of 2009 Total PR No-PR Provider PCP only 18600 321 (1.73) 18279 (98.3) 16695 389 (2.33) 16306 (97.7) 14529 384 (2.64) 14145 (97.4) PUL only 2989 94 (3.14) 2895 (96.9) 2647 (3.55) 2553 (96.5) 2516 78 (3.10) 2438 (96.9) PCP + PUL 9731 423 (4.35) 9308 (95.7) 10771 567 (5.26) 10204 (94.7) 11250 606 (5.39) 10644 (94.6) Others 2206 31 (1.41) 2175 (98.6) 2224 32 (1.44) 2192 (98.6) 1960 (1.63) 1928 (98.4) Elixhauser Comorbidity Score   8780 222 (2.53) 8558 (97.5) 6971 205 (2.94) 6766 (97.1) 5319 177 (3.33) 5142 (96.7) 1 9131 233 (2.55) 8898 8359 272 (3.25) 8087 (96.8) 7147 266 (3.72) 6881 (96.3) 2 6562 162 (2.47) 6400 6710 (3.47) 6477 (96.5) 6339 228 (3.60) 6111 (96.4) >=3 9053 252 (2.78) 8801 (97.2) 10297 372 (3.61) 9925 11450 429 (3.75) 11021

Patients level Pulmonary Rehabilitation sessions by year (%), 2003-2009   2003 2004 2005 2006 2007 2008 2009 sessions 1 – 4 57.7 54.6 55.7 57.0 52.8 56.5 5 – 8 26.7 28.4 26.9 25.9 24.9 25.6 24.6 >8 15.7 16.9 17.4 17.0 19.4 21.6 18.9 Among COPD patients who received pulmonary rehabilitation, there was a small increase in those participating in >8 sessions.

Multivariate Analysis Variable Model 1 Odds of PR (95% CI) Model 2 Diagnosed Year   2003 1.00 2004 1.20 (1.10 – 1.31) 1.18 (1.08 – 1.29) 2005 1.23 (1.12 – 1.34) 2006 1.30 (1.19 – 1.43) 1.26 (1.15 – 1.37) 2007 1.32 (1.20 – 1.44) 1.25 (1.15 – 1.37) 2008 1.35 (1.23 – 1.48) 1.28 (1.17 – 1.41) 2009 1.41 (1.29 – 1.55) Age Group 66 - 74 75 - 84 0.79 (0.75 – 0.84) >= 85 0.48 (0.43 – 0.53) Gender Male Female 0.97 (0.92 – 1.02) Race White Black 0.97 (0.76 – 1.25) Others 1.32 (1.14 – 1.53) Low socioeconomic No Yes 0.60 (0.55 – 0.66)

Multivariate Analysis Variable Model 1 Odds of PR (95% CI) Model 2 Comorbidity   1.00 1 1.01 (0.94 – 1.09) 2 1.10 (1.02 – 1.19) >=3 1.18 (1.10 – 1.26) Provider PCP only PUL only 1.44 (1.25 – 1.66) PCP + PUL 3.20 (2.78 – 3.69) Others 2.22 (1.89 – 2.60)

PR rate per 10,000 person-months among COPD patients (2003 – 2009) 22.2 26.5 27.1 28.7 29.0 29.7 31.0

Conclusions Factors associated with utilization of pulmonary rehabilitation: Age <75 yo Multiple comorbidities Higher socioeconomic status Involvement of a pulmonary physician in care PR utilization overall has increased from 2.59% to 3.64% (2003-2009) The number of sessions completed has also increased during that time period Overall, PR utilization remains low